Professional Documents
Culture Documents
®
Official reprint from UpToDate
®
www.uptodate.com ©2013 UpToDate
Disclosures
All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: May 2013. | This topic last updated: Mai 20, 2013.
INTRODUCTION — Obesity has become one of the most important public health problems in the
United States (figure 1) [1-3]. As the prevalence of obesity increases, so does the prevalence of the
comorbidities associated with obesity [4]. For this reason, it is imperative that health care providers
identify overweight and obese children so that counseling and treatment can be provided.
Recommendations, guidelines, and consensus statements for the evaluation and treatment of obese
children and adolescents have been published by the North American Society for Pediatric
Gastroenterology, Hepatology, and Nutrition (NASPGHAN) [5], an Expert Committee convened by the
Maternal and Child Health Bureau (MCHB) of the Health Resources and Services Administration
(HRSA) [6,7], the American Heart Association [8], the United States Preventive Services Task Force
(USPSTF) [9] an international Obesity Consensus Working Group [10], and the National Association
of Children’s Hospitals and Related Institutions (NACHRI) [11].
The clinical evaluation of the overweight child and adolescent will be presented here. Other aspects of
clinical management of obesity in children are discussed in separate topic reviews:
DIAGNOSIS — Calculation of body mass index (BMI) is a clinically practical tool for the assessment
of overweight and obesity in children. BMI is equal to the body weight (in kilograms) divided by the
height (in meters) squared (table 1). It correlates with adiposity [12-14] and complications of childhood
overweight [15-18]. Because BMI does not directly measure body fat, it may overestimate adiposity in
a child with increased muscle mass (eg, an athlete), and underestimate adiposity in a child with
reduced muscle mass (eg, a sedentary child). (See "Measurement of body composition in children",
section on 'Estimates of adiposity'.)
All children older than two years should have their BMI calculated at least annually from measured
height and weight [6,7,19,20]. The results should be plotted on an appropriate growth curve (figure 2A
-B). Health care providers typically underestimate weight status on casual examination, so it is
important to use measured heights and weights to determine and track obesity status [21]. (See "The
pediatric physical examination: General principles and standard measurements", section on 'Standard
measurements'.)
The BMI percentile and trend of percentile for age and sex determines whether the child is
underweight (<5th percentile), of normal weight (between 5th and 85th percentile), overweight (BMI
≥85th percentile and <95th percentile), or obese (≥95th percentile). BMI percentiles also can be
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 2 of 59
determined using a calculator for boys (calculator 1) and for girls (calculator 2). Management
strategies vary accordingly (algorithm 1). (See "Definition; epidemiology; and etiology of obesity in
children and adolescents".)
■ Increasing BMI trend – If the BMI is below the 85th percentile but has increased more than three
to four units (kg/m2) per year and begins to cross percentile lines, particularly if the child is older
than four years, the family should be warned that the child is at risk of becoming overweight
and be provided with simple tips for maintaining a healthy weight [6,20,22]. The tables give
examples of tips to help families improve nutrition and reduce caloric intake (table 2A-B and
table 3A-C), increase physical activity (table 4), and adopt parenting strategies to support these
goals (table 5).
■ Overweight – If the BMI is ≥85th percentile but less than the 95th percentile, the child is
overweight by definition. He or she should be screened for comorbidities of obesity (see
'Evaluation' below), and given counseling to optimize lifestyle habits with a goal of slowing the
rate of weight gain [6]. These families should be provided with information about healthy
lifestyle such as the tips outlined in the tables above. They also may benefit from direct
counseling from the clinician or from a dietitian to address their specific challenges (table 6).
■ Obese – If the BMI is ≥95th percentile, the child is obese by definition. He or she has a
significant likelihood of obesity in adulthood [23-26]. He or she should be carefully evaluated for
comorbidities of obesity, be provided with direct counseling from the clinician or allied health
care provider, and have regular follow-up to monitor progress [6]. (See 'Evaluation' below and
"Comorbidities and complications of obesity in children and adolescents".)
The age of the child and growth patterns of the family must be taken into consideration when
evaluating trends in BMI percentile [4]. The influence of maternal nutrition and intrauterine
environment are reflected primarily in the growth parameters at the time of birth, whereas genetic
factors have a later influence. Thus, the weight percentile of some children whose birthweight
percentile is less than what would be expected based upon family growth patterns may increase over
time. However, less than 5 percent of children cross two major percentiles lines upward on the growth
charts of the CDC after four years of age [27], and children who do so are at risk of overweight [4].
(See "Normal growth patterns in infants and prepubertal children", section on 'Determinants of normal
growth'.)
EVALUATION — The evaluation of the overweight or obese child should identify treatable causes
and comorbidities [4,7]. The evaluation should include a complete history and physical examination.
Laboratory and radiologic studies also may be obtained as indicated by the history and examination.
History — The history should include the age of onset of overweight and information about the child's
eating and exercise habits. The age of onset is helpful in distinguishing overfeeding from genetic
causes of overweight since syndromic obesity often has onset before two years of age (table 7A-B).
Information from the dietary and activity history may identify potential areas for intervention [4].
The dietary history should include the following factors, as summarized in the table (table 8) [4,28]:
■ Identification of foods high in calories and low in nutritional value that can be reduced,
eliminated, or replaced (eg, juice, soda)
■ Assessment of eating patterns (eg, timing, content, and location of meals and snacks); a child
or adolescent who feels unable to control consumption of large amounts of food may have an
eating disorder [29] (see "Eating disorders: Epidemiology, pathogenesis, clinical features, and
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 3 of 59
course of illness"). Children who eat less frequent meals (eg, those who skip meals) are more
likely to be obese than those who eat more frequently [30], but this association may not be
causal.
The activity history should include the following factors, as summarized in the table (table 9) [4]:
■ Evaluation of school recess and physical education (frequency, duration, and intensity)
The medical history should include review of all medications, particularly those that are known to be
weight-promoting (eg, certain psychoactive drugs such as risperidone, antiepileptic drugs, and
glucocorticoids) (table 10). (See "Definition; epidemiology; and etiology of obesity in children and
adolescents", section on 'Medications'.)
Review of systems — The review of systems should probe for evidence of comorbidities or
underlying etiologies (table 11) [4,7]. An abrupt onset of obesity with rapid weight gain should prompt
investigation of medication-induced weight gain, a major psychosocial trigger, endocrine causes of
obesity (eg, Cushing disease, hypothalamic tumor), or some obesity syndromes (Prader-Willi
syndrome, or rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic
dysregulation, and neural crest tumor [ROHHADNET syndrome]) [31]. (See "Definition; epidemiology;
and etiology of obesity in children and adolescents", section on 'Endocrine disease'.)
Family history — The risk of comorbidities of obesity is strongly influenced by the family history of
such morbidities, whether or not the affected family member is overweight [32]. Obesity in one or both
parents is an important predictor for whether a child's obesity will persist into adulthood [33-36]. Thus,
the family history should include information about obesity in first-degree relatives (parents and
siblings) [4]. It also should include information about common comorbidities of obesity, such as
cardiovascular disease, hypertension, diabetes, liver or gall bladder disease, and respiratory
insufficiency in first- and second-degree relatives (grandparents, uncles, aunts, half-siblings, nephews
and nieces).
Psychosocial history — The psychosocial history should include information related to:
■ Information about school and social issues (eg, does the child have friends? Is he or she a
target for teasing?)
■ Tobacco use, since cigarette smoking increases the long-term cardiovascular risk [7,37-
40] (see "Comorbidities and complications of obesity in children and adolescents")
Examination — As with the history, the examination of the overweight child or adolescent should
evaluate the presence of comorbidities and underlying etiologies. Key findings to note are shown in
the table (table 12).
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 4 of 59
The distribution of the excess fat may help to distinguish the etiology of obesity. The excess fat in
obesity from overeating or overfeeding usually is distributed in the trunk and periphery. In contrast, the
"buffalo type" distribution of body fat (concentrated in the interscapular area, face, neck, and trunk) is
suggestive of Cushing syndrome. (See "Definition; epidemiology; and etiology of obesity in children
and adolescents", section on 'Endocrine disease' and "Epidemiology and clinical manifestations of
Cushing's syndrome".)
Abdominal obesity (also called central, visceral, android, or male-type obesity) is associated with
certain comorbidities, including the metabolic syndrome, polycystic ovary syndrome, and insulin
resistance. Measurement of the waist circumference, in conjunction with calculation of the body mass
index (BMI), may help to identify patients at risk for these comorbidities. Abdominal obesity and
measurement of the waist circumference are discussed separately. (See "Measurement of body
composition in children", section on 'Fat distribution' and "Comorbidities and complications of obesity
in children and adolescents", section on 'Metabolic syndrome' and "Clinical features and diagnosis of
polycystic ovary syndrome in adolescents".)
Blood pressure — A careful blood pressure should be obtained with a proper sized cuff. The
bladder of the cuff should cover at least 80 percent of the arm circumference (the width of the bladder
will be about 40 percent of the arm circumference) (figure 3) [41]. In many children and adolescents
with obesity, this will require use of "adult" or "large adult" sized cuffs. Hypertension increases the long
-term cardiovascular risk in overweight or obese children [7]. In addition, hypertension may be a sign
of Cushing syndrome [4]. (See "Epidemiology and clinical manifestations of Cushing's syndrome".)
Hypertension is defined as a blood pressure greater than the 95th percentile for gender, age and
height on three separate occasions (table 13 and table 14). Age- and height-specific blood pressure
percentiles also may be determined using calculators for boys (calculator 3) or for girls (calculator 4).
(See "Definition and diagnosis of hypertension in children and adolescents".)
Stature — Assessment of stature and height velocity is useful in distinguishing exogenous obesity
from obesity that is secondary to genetic or endocrine abnormalities, including hypothalamic-pituitary
lesions [42,43]. Exogenous obesity drives linear height, so most obese children are tall for their age.
By contrast, most endocrine and genetic causes of obesity are associated with short stature (figure 4).
Growth velocity may be slowed in children with endocrine causes of obesity, and children with Prader-
Willi syndrome are often short for their genetic potential and/or fail to have a pubertal growth spurt.
(See "Clinical features, diagnosis, and treatment of Prader-Willi syndrome".)
Head, eyes, throat — Examination of the head, eyes, and throat may provide clues to the etiology
of obesity and/or comorbidities [7].
■ Blurred disc margins (picture 1) may indicate pseudotumor cerebri, an unexplained but not
uncommon association with obesity [44]. (See "Idiopathic intracranial hypertension
(pseudotumor cerebri): Clinical features and diagnosis".)
■ Clumps of pigment in the peripheral retina may indicate retinitis pigmentosa, which occurs in
Bardet-Biedl syndrome.
■ Enlarged tonsils may indicate obstructive sleep apnea. (See "Evaluation of suspected
obstructive sleep apnea in children".)
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 5 of 59
■ Erosion of the tooth enamel may indicate self-induced vomiting in patients with an eating
disorder. (See "Eating disorders: Epidemiology, pathogenesis, clinical features, and course of
illness".)
Skin and hair — Examination of the skin and hair is particularly useful in evaluating signs of
endocrine etiologies or complications [7]:
■ Dry, coarse, or brittle hair may be present in hypothyroidism. (See "Clinical manifestations of
hypothyroidism".)
■ Striae and ecchymoses are manifestations of Cushing syndrome; however, striae are much
more likely to be the result of rapid accumulation of subcutaneous fat.
■ Acanthosis nigricans (picture 2A-B) may signify type 2 diabetes or insulin resistance [45-47].
■ Hirsutism may be present in polycystic ovarian syndrome (PCOS) and Cushing syndrome.
Abdomen — Abdominal tenderness may be a sign of gallbladder disease [7]. Hepatomegaly may
be a clue to nonalcoholic fatty liver disease [7].
■ Postaxial polydactyly (an extra digit next to the fifth digit) may be present in Bardet-Biedl
syndrome [48], and small hands and feet may be present in Prader-Willi syndrome (table 7A-
B) [4]. (See "Clinical features, diagnosis, and treatment of Prader-Willi syndrome".)
■ The musculoskeletal examination may provide evidence of slipped capital femoral epiphysis
(limited range of motion at the hip, gait abnormality) or Blount disease (bowing of the lower
legs). (See "Slipped capital femoral epiphysis (SCFE)" and "Comorbidities and complications of
obesity in children and adolescents", section on 'Tibia vara (Blount disease)'.)
■ Dorsal finger callousness may be a clue to self-induced vomiting in patients with an eating
disorder [4]. (See "Eating disorders: Epidemiology, pathogenesis, clinical features, and course
of illness".)
Genitourinary — The genitourinary examination and evaluation of pubertal stage may provide
evidence of genetic or endocrine causes of obesity [4]. Evaluation of pubertal stage is discussed
separately. (See "Normal puberty", section on 'Sexual maturity rating (Tanner stages)' and "Clinical
features, diagnosis, and treatment of Prader-Willi syndrome", section on 'Hypogonadism'.)
■ Undescended testicles, small penis, and scrotal hypoplasia may indicate Prader-Willi
syndrome.
■ Delayed or absent puberty may occur in the presence of hypothalamic-pituitary tumors, Prader-
Willi syndrome, Bardet-Biedl syndrome, leptin deficiency, or leptin receptor deficiency.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 6 of 59
Development — Most of the syndromic causes of overweight in children are associated with
cognitive or developmental delay (table 7A-B). Prader-Willi syndrome is also associated with marked
hypotonia during infancy and delayed development of gross motor skills. (See "Clinical features,
diagnosis, and treatment of Prader-Willi syndrome", section on 'Behavior characteristics'.)
Laboratory studies
Suggested tests — The laboratory evaluation for overweight and obesity in children is not fully
standardized. Most experts suggest routine screening for type 2 diabetes mellitus, dyslipidemia,
hypertension, and fatty liver disease in children with BMI ≥85th or ≥95th percentile, using a basic panel
of tests (ie, fasting glucose, serum alanine aminotransferase [ALT], and lipid panel [total cholesterol,
triglycerides, LDL-cholesterol and HDL-cholesterol], and serum ALT) [7,8,10,42]. Some providers also
measure a fasting insulin level (for purposes of counseling rather than screening), as discussed
below. The recommended threshold for performing this screening varies slightly; an expert panel from
the United States National Heart, Lung, and Blood Institute (NHLBI) recommends initial lipid screening
for children between two and eight years of age with a BMI ≥95th percentile (or other risk factors for
cardiovascular disease), and for older children with a BMI ≥85th percentile [49]. Abnormal laboratory
tests can be an added stimulus for weight loss. The rationale for these laboratory tests is discussed in
detail separately. (See "Definition and screening for dyslipidemia in children" and "Comorbidities and
complications of obesity in children and adolescents".)
Assessment for other comorbidities including type 2 diabetes, sleep apnea, and polycystic ovary
syndrome, depends on the presence of risk factors or symptoms, as outlined in the table (table 15).
■ Screening for diabetes should be performed in children over 10 years of age who are
overweight or obese AND have two or more additional risk factors, which include a family
history of type 2 diabetes in a first- or second-degree relative, high-risk ethnicity, acanthosis
nigricans, or PCOS (table 16). For these patients, screening should consist of fasting plasma
glucose (FPG) or an oral glucose tolerance test (OGTT). Hemoglobin A1C (A1C) can be used
as an alternative to fasting glucose for patients who are not fasting. Patients with intermediate
or conflicting results for any of these tests should undergo repeat testing and be monitored for
future development of diabetes. Definitive diagnosis of diabetes mellitus requires meeting
diagnostic criteria on at least two separate occasions. (See "Epidemiology, presentation, and
diagnosis of type 2 diabetes mellitus in children and adolescents", section on 'Screening'.)
■ Vitamin D deficiency appears to be common among children and adolescents with obesity
either because of generalized vitamin and mineral deficiencies secondary to poor eating habits,
and/or due to sequestration in excess adipose tissue. In studies from Spain, Texas and New
York, Vitamin D deficiency was present in about half of children and adults with severe obesity,
and was associated with higher BMI and features of the metabolic syndrome [50-53]. However,
there is currently inadequate evidence to determine whether the risk of vitamin D deficiency is
sufficiently high in all populations of children with obesity to justify routine screening. Vitamin D
levels depend on several factors, including sunlight exposure, skin color, the use of sun screen,
and diet quality. (See "Vitamin D insufficiency and deficiency in children and adolescents",
section on 'Causes of vitamin D deficiency'.)
Interpretation of results
■ A fasting glucose of 100 to 125 mg/dL (5.55 to 6.94 mmol/L) is considered to be prediabetic,
and a level of ≥126 mg per dL (7.0 mmol/L) (on two occasions) is consistent with the diagnosis
of diabetes. Children with an elevated fasting glucose should have a confirmatory oral glucose
tolerance test (OGTT) or be referred to an endocrinologist for further evaluation. (See
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 7 of 59
■ Measurement of hemoglobin A1C (A1C) is a useful marker of the average blood glucose
concentration over the preceding 8 to 12 weeks. Because of improved assay standardization
and validation against other diagnostic methods, it can now be used for screening or to make a
diagnosis of diabetes mellitus, provided that an assay that is certified by the National
Glycohemoglobin Standardization Program (NGSP) is used. Patients with A1C 5.7-6.4 percent
are considered prediabetic (impaired glucose tolerance), and those with A1C ≥6.5 percent
probably have diabetes. Both groups of patients should have a confirmatory OGTT or be
referred to an endocrinologist for further evaluation. (See "Epidemiology, presentation, and
diagnosis of type 2 diabetes mellitus in children and adolescents", section on 'Hemoglobin
A1C'.)
■ Some providers measure fasting insulin because abnormal results can be helpful in explaining
clinical risks to patients and families. Other providers use the finding of acanthosis nigricans as
a basis for the same discussion. In either case, the provider can explain that there is a
significant likelihood that type 2 diabetes mellitus will eventually develop if weight loss is not
achieved (see "Pathogenesis of type 2 diabetes mellitus", section on 'Impaired insulin secretion
and insulin resistance'). Of note, the fasting insulin level should not be used as a clinical
screening tool for type 2 diabetes. It is an unreliable measure of insulin sensitivity, because it is
poorly correlated with whole body insulin sensitivity as measured by the euglycemic
hyperinsulinemic clamp. Moreover, currently there is no FDA-approved pharmacologic
treatment for isolated insulin resistance.
■ Fasting total cholesterol of >200 mg/dL (5.18 mmol/L) or a LDL cholesterol of >130 mg/dL (3.38
mmol/L) is consistent with hyperlipidemia (table 17). Obese children with hyperlipidemia should
be monitored and perhaps treated, since hyperlipidemia increases the risk of atherosclerosis as
the obese child grows older. Fasting serum triglycerides of >150 mg/dL (1.70 mmol/L) in
adolescents with obesity are considered to be elevated and an early sign of the "metabolic
syndrome". Non-fasting measurement of total cholesterol and non-HDL-cholesterol is an
acceptable alternative in children with low risk for cardiovascular disease, but fasting lipid
profiles are preferred for children with obesity. (See "Definition and screening for dyslipidemia
in children" and "Management of pediatric dyslipidemia".)
■ Liver function tests should be obtained because nonalcoholic fatty liver disease (NAFLD) is
typically asymptomatic [5]. Obese children with an elevation of ALT greater than two times the
norm that persists for greater than three months should be evaluated for the presence of
NAFLD and other chronic liver diseases (eg, viral hepatitis, autoimmune hepatitis, Wilson
disease, alpha-1 antitrypsin deficiency) [5]. (See "Comorbidities and complications of obesity in
children and adolescents", section on 'Nonalcoholic fatty liver disease'.)
■ If screening for vitamin D deficiency is undertaken, levels are measured as serum 25(OH)
vitamin D. The reference range varies by region, but levels <20 ng/mL are generally considered
deficient. In populations of children with obesity, vitamin D deficiency was not generally
associated with overt clinical symptoms [50,51]. However, if deficiency is found, vitamin D
supplementation should be initiated to avoid long-term consequences. (See "Treatment of
vitamin D deficiency in adults".)
Additional testing may be necessary if there are findings consistent with hypothyroidism, PCOS,
Cushing syndrome, and sleep apnea [5,8,10,54]. Syndromic obesity should be evaluated in children
with developmental delay or dysmorphic features (table 7A). Endocrine causes of obesity are unlikely
if the growth velocity is normal during childhood or early adolescence [42] (see 'Stature' above). Thus,
laboratory screening for hypothyroidism is rarely indicated in a child with normal growth velocity. Of
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 8 of 59
note, mildly elevated levels of thyroid stimulating hormone (TSH) are more often found in obese
children as compared to normal-weight children, but this is a consequence rather than a cause of the
obesity [55]. Moreover, most of the weight gain in hypothyroid individuals is due to accumulation of
salt and water, so hypothyroidism rarely causes substantial weight gain.
■ Plain radiographs of the lower extremities should be obtained if there are clinical findings
consistent with slipped capital femoral epiphysis (hip or knee pain, limited range of motion,
abnormal gait) or Blount disease (bowed tibia). (See "Slipped capital femoral epiphysis
(SCFE)".)
■ Abdominal ultrasonography may be indicated in children with findings consistent with gallstones
(eg, abdominal pain, abnormal transaminases) [7].
■ Abdominal ultrasonography also may be used to confirm the presence of fatty liver. However,
the severity of liver involvement does not correlate with radiographic findings. (See
"Comorbidities and complications of obesity in children and adolescents", section on
'Nonalcoholic fatty liver disease'.)
INDICATIONS FOR REFERRAL — Children who have comorbidities of obesity that require rapid
weight loss warrant referral to pediatric obesity centers for appropriate dietary, pharmacologic, and/or
surgical therapy [7,11]. These comorbidities include:
■ Type 2 diabetes, strong evidence of increased diabetes risk, or polycystic ovary syndrome
(PCOS) (should also be referred to a pediatric endocrinologist) (see "Epidemiology,
presentation, and diagnosis of type 2 diabetes mellitus in children and adolescents" and
"Clinical features and diagnosis of polycystic ovary syndrome in adolescents")
■ Sleep apnea (should also be referred to a pediatric sleep medicine specialist or pulmonologist)
(see "Evaluation of suspected obstructive sleep apnea in children")
■ Slipped capital femoral epiphysis or tibia vara (Blount disease) (should also be referred to a
pediatric orthopedist) (see "Slipped capital femoral epiphysis (SCFE)")
Other children who may merit referral to a pediatric obesity center include severely obese children
younger than two years, and children with severe obesity (eg, BMI ≥40 kg/m2, or ≥120 percent of the
95th percentile), even if they have no comorbidities [6]. Severely overweight children may benefit from
referral to a pediatric obesity specialist for more intensive therapy than can usually be provided by the
primary care provider.
Finally, certain overweight or obese children require referral to mental health specialists. These
include:
■ Overweight children who are depressed should be referred for psychologic evaluation and
treatment, since weight loss therapy may be ineffective without concurrent psychologic care [6].
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 9 of 59
■ Overweight children with findings suggestive of an eating disorder (eg, inability to control
consumption of large amounts of food, self-induced vomiting or laxative use to avoid weight
gain, dorsal finger lesions) should be evaluated by a therapist with experience in eating
disorders; such children require psychologic treatment and should not participate in weight
control programs without the concurrence of a therapist [6].
RESOURCES — Resources related to overweight in children and adolescents for health care
providers and families include:
INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, “The
Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at
the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have
about a given condition. These articles are best for patients who want a general overview and who
prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more
sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and
are best for patients who want in-depth information and are comfortable with some medical jargon.
Here are the patient education articles that are relevant to this topic. We encourage you to print or e-
mail these topics to your patients. (You can also locate patient education articles on a variety of
subjects by searching on “patient info” and the keyword(s) of interest.)
■ Obesity has become one of the most important public health problems in the United States
(figure 1) (see "Definition; epidemiology; and etiology of obesity in children and adolescents",
section on 'Epidemiology').
■ The body mass index (BMI) is the accepted standard measure of obesity and overweight in
children. It is equal to the body weight (in kilograms) divided by the height (in meters) squared
(table 1). "Obesity" is defined by a body mass index (BMI) ≥95th percentile for age and sex
(figure 2A-B), and "overweight" is defined by a BMI between the 85th and 94th percentile for age
and sex (figure 2A-B). (See 'Diagnosis' above.)
■ Height and weight should be measured and BMI calculated at least yearly in children older than
two years. Those who are overweight or obese should undergo evaluation to identify treatable
causes and comorbidities. (See "Definition; epidemiology; and etiology of obesity in children
and adolescents", section on 'Etiology' and "Comorbidities and complications of obesity in
children and adolescents".)
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 10 of 59
■ The evaluation should include a complete history and physical examination, with particular
attention to the signs and symptoms of comorbidities and genetic and endocrinologic causes of
overweight. (See 'History' above and 'Examination' above.)
■ Overweight or obese children and adolescents should undergo basic screening for dyslipidemia
and nonalcoholic fatty liver disease, with a fasting lipid panel and measurement of alanine
aminotransferase. The clinical utility of routine screening for insulin resistance or vitamin D
deficiency in this population has not been established. Overweight or obese children greater
than 10 years of age who have two or more risk factors including a family history of type 2
diabetes, high-risk ethnicity, acanthosis nigricans, or polycystic ovarian syndrome (PCOS)
should be screened for type 2 diabetes, using a fasting blood glucose and/or hemoglobin A1C
(table 16). Evaluation for other comorbidities should be performed as indicated by the history
and physical examination. (See 'Laboratory studies' above and 'Radiographic evaluation'
above.)
■ Overweight and obese children and adolescents with diabetes mellitus, PCOS, pseudotumor
cerebri, sleep apnea, obesity hypoventilation syndrome, fatty liver disease, slipped capital
femoral epiphysis, and tibia vara (Blount disease) should be referred to a pediatric obesity
specialist for weight control. We also recommend referral for obese children younger than two
years. (See 'Indications for referral' above.)
■ Overweight and obese children and adolescents with symptoms and signs of depression
should be referred for psychologic evaluation and treatment. (See "Depression in adolescents:
Epidemiology, clinical manifestations, and diagnosis".)
■ Overweight and obese children and adolescents with symptoms and signs of an eating disorder
should be evaluated by a therapist with experience in eating disorders. We recommend that
such patients should not participate in weight control programs without the concurrence of their
therapist. (See "Eating disorders: Epidemiology, pathogenesis, clinical features, and course of
illness" and "Eating disorders: Overview of treatment".)
REFERENCES
1. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US
children and adolescents, 1999-2000. JAMA 2002; 288:1728.
2. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001;
286:2845.
3. Jolliffe D. Extent of overweight among US children and adolescents from 1971 to 2000. Int J
Obes Relat Metab Disord 2004; 28:4.
4. Dietz WH, Robinson TN. Clinical practice. Overweight children and adolescents. N Engl J Med
2005; 352:2100.
5. Baker S, Barlow S, Cochran W, et al. Overweight children and adolescents: a clinical report of
the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr
Gastroenterol Nutr 2005; 40:533.
6. Barlow SE, Expert Committee. Expert committee recommendations regarding the prevention,
assessment, and treatment of child and adolescent overweight and obesity: summary report.
Pediatrics 2007; 120 Suppl 4:S164.
7. Krebs NF, Himes JH, Jacobson D, et al. Assessment of child and adolescent overweight and
obesity. Pediatrics 2007; 120 Suppl 4:S193.
8. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents:
pathophysiology, consequences, prevention, and treatment. Circulation 2005; 111:1999.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 11 of 59
9. US Preventive Services Task Force, Barton M. Screening for obesity in children and
adolescents: US Preventive Services Task Force recommendation statement. Pediatrics 2010;
125:361.
10. Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab 2005;
90:1871.
11. Young KL, Demeule M, Stuhlsatz K, et al. Identification and treatment of obesity as a standard
of care for all patients in children's hospitals. Pediatrics 2011; 128 Suppl 2:S47.
12. Dietz WH, Robinson TN. Use of the body mass index (BMI) as a measure of overweight in
children and adolescents. J Pediatr 1998; 132:191.
13. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age-
and sex-specific prediction formulas. Br J Nutr 1991; 65:105.
14. Freedman DS, Wang J, Maynard LM, et al. Relation of BMI to fat and fat-free mass among
children and adolescents. Int J Obes (Lond) 2005; 29:1.
15. Clarke WR, Woolson RF, Lauer RM. Changes in ponderosity and blood pressure in childhood:
the Muscatine Study. Am J Epidemiol 1986; 124:195.
16. Gidding SS, Bao W, Srinivasan SR, Berenson GS. Effects of secular trends in obesity on
coronary risk factors in children: the Bogalusa Heart Study. J Pediatr 1995; 127:868.
17. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to
cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study.
Pediatrics 1999; 103:1175.
18. Raitakari OT, Porkka KV, Räsänen L, et al. Clustering and six year cluster-tracking of serum
total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The
Cardiovascular Risk in Young Finns Study. J Clin Epidemiol 1994; 47:1085.
19. Krebs NF, Jacobson MS, American Academy of Pediatrics Committee on Nutrition. Prevention
of pediatric overweight and obesity. Pediatrics 2003; 112:424.
20. Institute of Medicine. Preventing childhood obesity: health in the balance. Institute of Medicine,
Washington, D.C., 2004. www.iom.edu/report.asp?id=22596 (Accessed on September 26,
2006).
21. Smith SM, Gately P, Rudolf M. Can we recognise obesity clinically? Arch Dis Child 2008;
93:1065.
22. Miller LA, Grunwald GK, Johnson SL, Krebs NF. Disease severity at time of referral for pediatric
failure to thrive and obesity: time for a paradigm shift? J Pediatr 2002; 141:121.
23. Guo SS, Roche AF, Chumlea WC, et al. The predictive value of childhood body mass index
values for overweight at age 35 y. Am J Clin Nutr 1994; 59:810.
24. Mossberg HO. 40-year follow-up of overweight children. Lancet 1989; 2:491.
25. Stark O, Atkins E, Wolff OH, Douglas JW. Longitudinal study of obesity in the National Survey of
Health and Development. Br Med J (Clin Res Ed) 1981; 283:13.
26. Braddon FE, Rodgers B, Wadsworth ME, Davies JM. Onset of obesity in a 36 year birth cohort
study. Br Med J (Clin Res Ed) 1986; 293:299.
27. Mei Z, Grummer-Strawn LM, Thompson D, Dietz WH. Shifts in percentiles of growth during early
childhood: analysis of longitudinal data from the California Child Health and Development Study.
Pediatrics 2004; 113:e617.
28. Hoppin, AG. Obesity. In: Pediatric Gastrointestinal Disease: Pathopsychology, Diagnosis,
Management, 4th ed, Walker, WA, Goulet, O, Kleinman, RE, et al (Eds), BC Decker, Ontario,
2004. p. 311.
29. Morgan CM, Yanovski SZ, Nguyen TT, et al. Loss of control over eating, adiposity, and
psychopathology in overweight children. Int J Eat Disord 2002; 31:430.
30. Kaisari P, Yannakoulia M, Panagiotakos DB. Eating Frequency and Overweight and Obesity in
Children and Adolescents: A Meta-analysis. Pediatrics 2013; 131:958.
31. Bougnères P, Pantalone L, Linglart A, et al. Endocrine manifestations of the rapid-onset obesity
with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in
childhood. J Clin Endocrinol Metab 2008; 93:3971.
32. Pediatric Obesity. In: Pediatric Nutrition Handbook, 6th ed, Kleinman R (Ed), American
Academy of Pediatrics, Elk Grove Village, IL 2009. p.733.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 12 of 59
33. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood
and parental obesity. N Engl J Med 1997; 337:869.
34. Blair NJ, Thompson JM, Black PN, et al. Risk factors for obesity in 7-year-old European
children: the Auckland Birthweight Collaborative Study. Arch Dis Child 2007; 92:866.
35. Reilly JJ, Armstrong J, Dorosty AR, et al. Early life risk factors for obesity in childhood: cohort
study. BMJ 2005; 330:1357.
36. Rudolf M. Predicting babies' risk of obesity. Arch Dis Child 2011; 96:995.
37. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk
factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J
Med 1998; 338:1650.
38. Nilsson PM, Lind L, Pollare T, et al. Increased level of hemoglobin A1c, but not impaired insulin
sensitivity, found in hypertensive and normotensive smokers. Metabolism 1995; 44:557.
39. Axelsen M, Eliasson B, Joheim E, et al. Lipid intolerance in smokers. J Intern Med 1995;
237:449.
40. Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the
metabolic syndrome in adolescents. Circulation 2005; 112:862.
41. National High Blood Pressure Education Program Working Group on High Blood Pressure in
Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high
blood pressure in children and adolescents. Pediatrics 2004; 114:555.
42. August GP, Caprio S, Fennoy I, et al. Prevention and treatment of pediatric obesity: an
endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab
2008; 93:4576.
43. Taylor M, Couto-Silva AC, Adan L, et al. Hypothalamic-pituitary lesions in pediatric patients:
endocrine symptoms often precede neuro-ophthalmic presenting symptoms. J Pediatr 2012;
161:855.
44. Brara SM, Koebnick C, Porter AH, Langer-Gould A. Pediatric idiopathic intracranial hypertension
and extreme childhood obesity. J Pediatr 2012; 161:602.
45. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-
dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics
1997; 100:84.
46. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acanthosis
nigricans in an adult obese population. Arch Dermatol 1992; 128:941.
47. Brickman WJ, Huang J, Silverman BL, Metzger BE. Acanthosis nigricans identifies youth at high
risk for metabolic abnormalities. J Pediatr 2010; 156:87.
48. Green JS, Parfrey PS, Harnett JD, et al. The cardinal manifestations of Bardet-Biedl syndrome,
a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989; 321:1002.
49. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children
and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated
guidelines for cardiovascular health and risk reduction in children and adolescents: summary
report. Pediatrics 2011; 128 Suppl 5:S213.
50. Smotkin-Tangorra M, Purushothaman R, Gupta A, et al. Prevalence of vitamin D insufficiency in
obese children and adolescents. J Pediatr Endocrinol Metab 2007; 20:817.
51. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated
with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26:573.
52. Kelly A, Brooks LJ, Dougherty S, et al. A cross-sectional study of vitamin D and insulin
resistance in children. Arch Dis Child 2011; 96:447.
53. Turer CB, Lin H, Flores G. Prevalence of vitamin D deficiency among overweight and obese US
children. Pediatrics 2013; 131:e152.
54. Yanovski JA, Cutler GB Jr. Glucocorticoid action and the clinical features of Cushing's
syndrome. Endocrinol Metab Clin North Am 1994; 23:487.
55. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after
weight loss and is not related to lipids. J Clin Endocrinol Metab 2006; 91:3088.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 13 of 59
GRAPHICS
* Children with body mass index (BMI) values at or above the 95th percentile of the sex-specific body mass
index (BMI) growth charts released by the Centers for Disease Control (CDC) in 2000.
National Health and Nutrition Examination Surveys. Additional information is available at:
http://www.cdc.gov/nchs/fastats/overwt.htm.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 14 of 59
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 15 of 59
Developed by the National Center for Health Statistics in collaboration with the National Center
for Chronic Disease Prevention and Health Promotion (2000).
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 16 of 59
Developed by the National Center for Health Statistics in collaboration with the National Center
for Chronic Disease Prevention and Health Promotion (2000).
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 17 of 59
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 18 of 59
Phase I
Choose sugar-free beverages or low-fat milk only
Choose sugar-free beverages, water or low-fat (skim, one-half percent, and 1
percent) milk.
Limit milk to 16 to 24 ounces per day. Avoid flavored milks, including fat-free
versions.
Have fast food no more than once a week, and try the following healthier
options:
Choose plain hamburger kid's meal with water, diet soda, or skim milk.
Try a grilled chicken sandwich ordered without mayonnaise with a piece of fruit
from home.
Avoid burgers with double meat, cheese, bacon, mayonnaise, and super-sized
french fries.
Healthy breakfast ideas: two pieces whole wheat toast with a glass of skim milk;
small bowl of cereal such as bran flakes, Cheerios or old-fashioned oat meal with
skim milk; or a fat-free yogurt and a piece of fresh fruit.
Try the Plate Method at dinner. Design a dinner plate with one-half a plate of
vegetables, one-quarter plate of lean meat, and one-quarter plate of starch or
starchy vegetables (potatoes, corn, or peas) (see www.choosemyplate.gov). Avoid
second helpings.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 19 of 59
Phase II
Eat a variety of foods.
Eat fruits, vegetables, whole grain breads, cereals, rice, and pastas; low-fat and fat
-free dairy products; lean chicken, turkey, fish, and legumes; and healthy fats. Use
a small amount of added fats and sugars. Avoid fried foods. See the Low-fat, Low-
Sugar Eating Guidelines for a list of food choices and sample menus.
Young children and inactive girls should choose the lower number of servings from
each food group. Most active school-aged children and teen girls, as well as
inactive teen boys should choose the middle number of servings. Active teen boys
and some very active teen girls should choose the higher number of servings from
each food group.
Number of
Group servings per Serving size
day
Bread, cereal, rice, 6 to 11 1 slice whole wheat bread; 1/2 cup cooked
pasta and starchy whole-grain cereal, brown rice, or whole
vegetable wheat pasta
Eliminate unhealthful food choices from your house including low-fat cookies, cakes
and ice cream as these foods are often enriched with sugar. Instead, stock your
house with fresh fruit, cut up vegetables and fat-free or low-fat yogurt. Children
can choose between an apple or yogurt for a snack, not an apple or potato chips.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 20 of 59
Fruits Whole fresh and frozen fruits Canned fruit, fruit juices, dried
such as apple, banana, fruit and fried fruits
blueberries, cantaloupe,
cherries, grapefruit, grapes,
honeydew melon, kiwi, mango,
orange, peach, pear, pineapple,
plums, and strawberries
Meat, poultry, Fish, shellfish, skinned white- Regular beef, pork, lamb, veal,
fish, dried meat chicken and turkey, and luncheon meats; fried
beans, eggs beans, peas, lentils, egg chicken and fish, eggs, sausage,
substitutes, egg whites, hot dogs
soybeans, and tofu
Milk, yogurt Skim and 1 percent milk, plain 2 percent and whole milk, 1
and cheese nonfat yogurt, nonfat yogurt percent and whole chocolate
sweetened with aspartame or milk, goat's milk, kefir, low-fat
nonnutritive sweetener; fat-free yogurt (plain or fruit flavored),
or low-fat cheese and cottage custard-style yogurt, regular
cheese cheese and cottage cheese
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 21 of 59
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 22 of 59
2/3 cup steamed/boiled 1 cup lettuce and tomato salad 1/2 cup steamed
brown rice with 1/8 avocado slice turnip greens
2 cups mixed salad Water or unsweetened iced tea 1 small whole grain
greens roll with 1
Snack tablespoon light
1 tablespoon balsamic margarine
vinegar with 2 1/2 mango
teaspoons olive oil Water or
1 cup fat-free, reduced-calorie unsweetened iced
1/2 cup steamed green yogurt with 1 ounce almond tea
beans slivers
Snack
Water with lemon
6 cups low-fat
Snack popcorn
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 23 of 59
1 ounce peanuts
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 24 of 59
Exercise Phase I
Begin decreasing time spent in sedentary activities.
Identify how many hours per day your family spends in sedentary activities such as
watching TV, playing video games, and surfing the internet and make efforts to
decrease this time every day this week. Explore ways to be physically active on a
daily basis.
Exercise Phase II
Decrease sedentary time
Limit television, video games and computer time to no more than 1 hour per day.
Limiting sedentary time will encourage children to choose other activities, most of
which will generate increased physical activity. Buy active toys rather than
computer games or videotapes. Define indoor areas for physical play such as "Nerf"
balls, bouncy balls or scooter toys.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 25 of 59
Focus on the whole family, and not just the overweight child.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 26 of 59
Family frequently eats meals Identify barriers that prevent families from eating
away from home at home more often.
Poor dietary quality (lack of Provide education about food groups, discussing
fruits/vegetables and whole the importance of each food group as part of the
grains, consumption of whole daily diet.
milk, etc...)
One approach is to discuss the concept of a
"balanced plate," focusing on supplying ample
vegetables, fruits and fiber (approximately 1/4
plate each for vegetables, grains, fruits, and
protein). Guidance available at
www.choosemyplate.gov.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 27 of 59
Excessive refined grains (white Emphasize the importance of including fiber in the
bread) and simple diet as a means of decreasing hunger and feeling
carbohydrates (sugars) full after eating.
Low fruit and vegetable intake Provide education regarding serving sizes of
vegetables and fruits.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 28 of 59
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 29 of 59
Obesity
Clinical
Syndrome Locus Gene onset
features
(type)
Albright hereditary 20q13.2 GNAS1 Early Short stature,
osteodystrophy (generalized) short
(Pseudohypoparathyroidism metacarpals and
type 1a) (MIM #103580) metatarsals,
round facies,
delayed
dentition, +/−
hypocalcemia
and/or
subcutaneous
calcium or bone
deposition
(osteoma cutis),
precocious
puberty, mild
cognitive deficit
4q27 BBS7
14q32 BBS8
(TTC8)
7p14 BBS9
12q BBS10
9q33.1 BBS11
(TRIM32)
4q27 BBS12
17q23 BBS13
(MKS1)
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 30 of 59
12q21.3 BBS14
(CEP290)
2p15 BBS15
(C2ORF86)
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 31 of 59
Adapted from:
1. Pediatric Obesity. In: Pediatric Nutrition Handbook, 6th ed, Kleinman R (Ed), American
Academy of Pediatrics, Elk Grove Village, IL, 2009. p.751
2. Hoppin AG. Obesity. In: Pediatric Gastrointestinal Disease: Pathopsychology, Diagnosis,
Management, 4th ed, Walker WA, Goulet O, Kleinman, RE, et al (Eds), BC Decker,
Ontario, 2004. p.311.
3. Leibel RL, Chua SC, Rosenbaum M. Obesity. In: The Metabolic and Molecular Bases of
Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill,
New York, 2001. p.3965.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 32 of 59
Single gene
Chromosome Clinical features
disorder
Leptin deficiency (LEP) 7q31.3 Severe, early onset obesity,
hypometabolic rate, hyperphagia,
pubertal delay, impaired glucose
tolerance, hypothalamic
hypogonadism
Adapted from:
1. Hoppin AG. Obesity. In: Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis
and Management, 4th ed, Walker WA, Goulet O, Kleinman RE, et al (Eds), BC Decker,
Ontario, 2004. p.311
2. Leibel RL, Chua SC, Rosenbaum M. Obesity. In: The Metabolic and Molecular Bases of
Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill,
New York, 2001. p.3965.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 33 of 59
Examples of
Nutritional Contribution to weight
questions for clinical
factor gain
assessment
Restaurants Meals eaten away from home "How many times a week
and fast food increase portion size and total does your family get
energy intake, and are of poorer takeout food?"
[1-6]
nutrient quality . Increased
frequency of eating meals away "How many meals a week
from home is associated with does your family eat at a
[7,8] restaurant or eat fast food?"
increased BMI .
Fruits and Eating fruits and vegetables may "What fruits and vegetables
vegetables displace more energy dense foods do you currently have in
and increase satiety. There is some your home?"
evidence that low consumption of
these foods is associated with "How often does your child
obesity [16-18]. eat vegetables at lunch or
dinner?"
Breakfast Skipping breakfast associated with "When is the first time your
increasing obesity in children child typically
despite perceived decrease in daily has something to eat or
[19-23] drink after waking up?"
caloric intake , and has
adverse effects on school
[24-26] "Does your child eat
performance .
breakfast at home or at
school?"
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 34 of 59
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 35 of 59
References:
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 36 of 59
1. Whitlock EP, O'Connor EA, Williams SB, Beil TL, Lutz KW. Effectiveness of Weight
Management Interventions in Children: A Targeted Systematic Review for the USPSTF.
Pediatrics 2010.
2. Paeratakul S, Ferdinand DP, Champagne CM, Ryan DH, Bray GA. Fast-food consumption
among US adults and children: dietary and nutrient intake profile. J Am Diet Assoc 2003;
103:1332-8.
3. Diliberti N, Bordi PL, Conklin MT, Roe LS, Rolls BJ. Increased portion size leads to
increased energy intake in a restaurant meal. Obes Res 2004; 12:562-8.
4. Bowman SA, Gortmaker SL, Ebbeling CB, Pereira MA, Ludwig DS. Effects of fast-food
consumption on energy intake and diet quality among children in a national household
survey. Pediatrics 2004; 113:112-8.
5. French SA, Story M, Neumark-Sztainer D, Fulkerson JA, Hannan P. Fast food restaurant
use among adolescents: associations with nutrient intake, food choices and behavioral
and psychosocial variables. Int J Obes Relat Metab Disord 2001; 25:1823-33.
6. Nielsen SJ, Siega-Riz AM, Popkin BM. Trends in food locations and sources among
adolescents and young adults. Prev Med 2002; 35:107-13.
7. Schmidt M, Affenito SG, Striegel-Moore R, Khoury PR, Barton B, Crawford P, Kronsberg S,
Schreiber G, Obarzanek E, Daniels S. Fast-food intake and diet quality in black and white
girls: the National Heart, Lung, and Blood Institute Growth and Health Study. Arch Pediatr
Adolesc Med 2005; 159:626-31.
8. Thompson OM, Ballew C, Resnicow K, Must A, Bandini LG, Cyr H, Dietz WH. Food
purchased away from home as a predictor of change in BMI z-score among girls. Int J
Obes Relat Metab Disord 2004; 28:282-9.
9. Pereira MA, Kartashov AI, Ebbeling CB, Van Horn L, Slattery ML, Jacobs DR Jr, Ludwig DS.
Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year
prospective analysis. Lancet 2005; 365:36-42.
10. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-
sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet
2001; 357:505-8.
11. Harnack L, Stang J, Story M. Soft drink consumption among US children and adolescents:
nutritional consequences. J Am Diet Assoc 1999; 99:436-41.
12. Tordoff MG, Alleva AM. Effect of drinking soda sweetened with aspartame or high-fructose
corn syrup on food intake and body weight. Am J Clin Nutr 1990; 51:963-9.
13. Lewis CJ, Park YK, Dexter PB, Yetley EA. Nutrient intakes and body weights of persons
consuming high and moderate levels of added sugars. J Am Diet Assoc 1992; 92:708-13.
Rolls BJ, Engell D, Birch LL. Serving portion size influences 5-year-old but not 3-year-old
children's food intakes. J Am Diet Assoc 2000; 100:232-4.
14. Krebs NF, Himes JH, Jacobson D, Nicklas TA, Guilday P, Styne D. Assessment of child and
adolescent overweight and obesity. Pediatrics 2007; 120 Suppl 4:S193-228.
15. Orlet Fisher J, Rolls BJ, Birch LL. Children's bite size and intake of an entree are greater
with large portions than with age-appropriate or self-selected portions. Am J Clin Nutr
2003; 77:1164-70.
16. McCrory MA, Fuss PJ, Hays NP, Vinken AG, Greenberg AS, Roberts SB. Overeating in
America: association between restaurant food consumption and body fatness in healthy
adult men and women ages 19 to 80. Obes Res 1999; 7:564-71.
17. Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK. Fruit and
vegetable intake and risk of cardiovascular disease in US adults: the first National Health
and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 2002;
76:93-9.
18. Maskarinec G, Novotny R, Tasaki K. Dietary patterns are associated with body mass index
in multiethnic women. J Nutr 2000; 130:3068-72.
19. Wolfe WS, Campbell CC, Frongillo EA Jr, Haas JD, Melnik TA. Overweight schoolchildren in
New York State: prevalence and characteristics. Am J Public Health 1994; 84:807-13.
20. Gibson SA, O'Sullivan KR. Breakfast cereal consumption patterns and nutrient intakes of
British schoolchildren. J R Soc Health 1995; 115:366-70.
21. Ortega RM, Requejo AM, Lopez-Sobaler AM, Quintas ME, Andres P, Redondo MR, Navia B,
Lopez-Bonilla MD, Rivas T. Difference in the breakfast habits of overweight/obese and
normal weight schoolchildren. Int J Vitam Nutr Res 1998; 68:125-32.
22. Pastore DR, Fisher M, Friedman SB. Abnormalities in weight status, eating attitudes, and
eating behaviors among urban high school students: correlations with self-esteem and
anxiety. J Adolesc Health 1996; 18:312-9.
23. Summerbell CD, Moody RC, Shanks J, Stock MJ, Geissler C. Relationship between feeding
pattern and body mass index in 220 free-living people in four age groups. Eur J Clin Nutr
1996; 50:513-9.
24. Wyatt HR, Grunwald GK, Mosca CL, Klem ML, Wing RR, Hill JO. Long-term weight loss and
breakfast in subjects in the National Weight Control Registry. Obes Res 2002; 10:78-82.
25. Murphy JM, Pagano ME, Nachmani J, Sperling P, Kane S, Kleinman RE. The relationship of
school breakfast to psychosocial and academic functioning: cross-sectional and
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 37 of 59
longitudinal observations in an inner-city school sample. Arch Pediatr Adolesc Med 1998;
152:899-907.
26. Ross MM, Kolbash S, Cohen GM, Skelton JA. Multidisciplinary treatment of pediatric
obesity: nutrition evaluation and management. Nutr Clin Pract 2010; 25:327-34.
Data from:
Krebs NF, et al. Pediatrics 2007; 120:S193.
Ross MM, et al. Nutr Clin Pract 2010; 25:327.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 38 of 59
Sedentary behaviors
Hours spent watching television, including videos or movies
Hours spent doing productive sedentary behaviors, such as homework, reading, and
computer-based learning
Time spent in unstructured play (eg, outside play, and routine activity such as
walking to school)
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 39 of 59
Anti-depressants
Tricyclics Amitriptyline, Clomipramine, Doxepin, Protriptyline
Imipramine, Nortriptyline
Antihistamines Cyproheptidine
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 40 of 59
Additional studies or
Symptom Potential significance
referral
Delayed Genetic syndrome Pediatric geneticist and/or
development neurologist
ENT: ear/nose/throat.
Adapted from: Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee
recommendations. The Maternal and Child Health Bureau, Health Resources and Services
Administration and the Department of Health and Human Services. Pediatrics 1998; 102:E29
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 41 of 59
and Dietz WH, Robinson TN. Clinical practice. Overweight children and adolescents. N Engl J
Med 2005; 352:2100.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 42 of 59
Exam
Definition Clinical concern raised
finding
Endocrine or genetic condition
Short stature Height <50th percentile with (eg, Cushing syndrome)
weight >95th percentile* (if not
OR explained by familial short
unexplained stature)
decrease in
height velocity Growth velocity <5 cm/year in a
prepubertal child, or declining
across over two or more height
percentile curves on a standard
chart (eg, decreasing from the
90th to the 50th percentile)
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 43 of 59
of motion in
hip
* Most children with obesity who have not completed linear growth are relatively tall for their
age. Therefore, height <50th percentile is unusual.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 44 of 59
The width of the bladder of the blood pressure cuff should be approximately 40
percent of the circumference of the upper arm midway between the olecranon
and the acromion. The length of the bladder of the cuff should encircle 80 to 100
percent of the circumference of the upper arm at the same position.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 45 of 59
1 th 80 81 83 85 87 88 89 34 35 36 37
50
2 th 84 85 87 88 90 92 92 39 40 41 42
50
th 97 99 100 102 104 105 106 54 55 56 57
90
3 th 86 87 89 91 93 94 95 44 44 45 46
50
th 100 101 103 105 107 108 109 59 59 60 61
90
th 104 105 107 109 110 112 113 63 63 64 65
95
4 th 88 89 91 93 95 96 97 47 48 49 50
50
th 102 103 105 107 109 110 111 62 63 64 65
90
th 106 107 109 111 112 114 115 66 67 68 69
95
th 113 114 116 118 120 121 122 74 75 76 77
99
5 50th 90 91 93 95 96 98 98 50 51 52 53
6 th 91 92 94 96 98 99 100 53 53 54 55
50
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 46 of 59
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 47 of 59
th th
The 90 percentile is 1.28 standard deviation, 95 percentile is 1.645 standard
th
deviation, and the 99 percentile is 2.326 over the mean.
BP: blood pressure.
From: the Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in
children and adolescents. National Heart, Lung and Blood Institute. National Institutes of
Health. May 2004.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 48 of 59
1 th 83 84 85 86 88 89 90 38 39 39 40
50
2 th 85 85 87 88 89 91 91 43 44 44 45
50
th 98 99 100 101 103 104 105 57 58 58 59
90
3 th 86 87 88 89 91 92 93 47 48 48 49
50
th 100 100 102 103 104 106 106 61 62 62 63
90
th 104 104 105 107 108 109 110 65 66 66 67
95
4 th 88 88 90 91 92 94 94 50 50 51 52
50
th 101 102 103 104 106 107 108 64 64 65 66
90
th 105 106 107 108 110 111 112 68 68 69 70
95
th 112 113 114 115 117 118 119 76 76 76 77
99
5 50th 89 90 91 93 94 95 96 52 53 53 54
6 th 91 92 93 94 96 97 98 54 54 55 56
50
7 50th 93 93 95 96 97 99 99 55 56 56 57
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 49 of 59
8 th 95 95 96 98 99 100 101 57 57 57 58
50
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 50 of 59
th th
The 90 percentile is 1.28 standard deviation, 95 percentile is 1.645 standard
th
deviation, and the 99 percentile is 2.326 over the mean.
BP: blood pressure.
From: the Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in
children and adolescents. National Heart, Lung and Blood Institute. National Institutes of
Health. May 2004.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 51 of 59
Growth chart of a girl diagnosed with Cushing's disease at age 11.25 years. The patient
had poor height velocity since age 9.6 years in conjunction with a 2.25-year delayed bone
age (leftward arrow from height point at actual age 11.25 years), and excessive weight
gain over the same time period. An ACTH-producing pituitary adenoma was discovered and
removed by trans-sphenoidal surgery at age 11.5 years. The patient subsequently had full
biochemical recovery, initially followed by a significant improvement in height velocity and
a significant reduction in weight (loss of 16 pounds over 6 months). With progressive
puberty, the patient's bone age delay decreased (1.25 years at actual age 12.25 years,
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 52 of 59
and 0.5 years at actual age 14 years) in association with physiological height plateauing.
The progressive acceleration in bone age was likely due to the effects of pubertal estrogen.
The bracket at the far right of the height curve represents the mid-parental target height
range (±1 SD). As is typical in patients with childhood Cushing's disease, the mid-parental
[1]
target height was not achieved.
ACTH: adrenocorticotropic hormone; GnRH: gonadotropin hormone releasing hormone; SD: standard
deviation; %: percent.
Reference:
1. Chan LF, Storr HL, Grossman AB, Savage MO. Pediatric Cushing's syndrome: Clinical features,
diagnosis, and treatment. Arq Bras Endocrinol Metabol 2007; 51:1261-1271.
Courtesy of Mitchell Geffner, MD.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 53 of 59
Papilledema
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 54 of 59
Acanthosis nigricans
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 55 of 59
Acanthosis nigricans
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 56 of 59
Type 2 diabetes Fasting glucose, oral Assess for insulin Fasting glucose
mellitus or glucose tolerance resistance, renal ≥126 mg/dL or
impaired glucose test, HbA1c, urinary involvement HbA1c ≥6.5
tolerance microalbumin percent indicates
diabetes. Fasting
glucose 100-125
mg/dL or HbA1c
5.7-6.4 percent
considered pre-
diabetes.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 57 of 59
BP: blood pressure; CBC: complete blood count; AST: aspartate aminotransferase; ALT: alanine
aminotransferase; ANA: antinuclear antibodies; HbA1c: hemoglobin A1c; SCFE: slipped capital
femoral epiphysis; DHEAS: dehydroepiandrosterone sulfate; SHBG: sex hormone binding
globulin; LH: luteinizing hormone; FSH: follicle-stimulating hormone.
Adapted from:
1. Barlow SE. Expert committee recommendations regarding the prevention, assessment,
and treatment of child and adolescent overweight and obesity: summary report.
Pediatrics. 2007 Dec; 120 Suppl 4:S164-92.
2. Krebs NF, et al. Assessment of child and adolescent overweight and obesity. Pediatrics.
2007 Dec; 120 Suppl 4:S193-228.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 58 of 59
Overweight status
Body mass index ≥85th percentile for age and gender
Screening frequency
Begin screening at age 10 years, or at onset of puberty if this occurs less than 10
years old
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013
Clinical evaluation of the obese child and adolescent Page 59 of 59
Acceptable Borderline ∆
Category High
mg/dL (mmol/L) mg/dL (mmol/L)
TC <170 (4.4) 170-199 (4.4-5.2) ≥200 (5.2)
TG
• 0-9 years <75 (0.8) 75-99 (0.8-1.1) ≥100 (1.1)
∆
Category Acceptable Borderline Low
HDL-C >45 (1.2) 40-45 (1-1.2) <40 (1.0)
* Values for plasma lipid and lipoprotein levels are from the National Cholesterol Education
Program (NCEP) Expert Panel on Cholesterol Levels in Children. Non-HDL-C values from the
Bogalusa Heart Study are equivalent to the NCEP Pediatric Panel cut points for LDL-C. Values
for plasma apoB and apoA-1 are from the National Health and Nutrition Examination Survey III.
∆ The threshold points for high and borderline-high values represent approximately the 95th
and 75th percentiles, respectively. Low threshold points for HDL-C and apoA-1 represent
approximately the 10th percentile.
http://www.uptodate.com/contents/clinical-evaluation-of-the-obese-child-and-adolesc... 19-06-2013